<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Physiol Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Physiol Rep</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2051-817X</journal-id>
<journal-id journal-id-type="publisher-id">PHY2</journal-id>
<journal-id journal-id-type="hwp">physreports</journal-id>
<journal-title-group>
<journal-title>Physiological Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2051-817X</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27252250</article-id>
<article-id pub-id-type="pmc">4908484</article-id>
<article-id pub-id-type="doi">10.14814/phy2.12769</article-id>
<article-id pub-id-type="publisher-id">PHY212769</article-id>
<article-categories>
<subj-group subj-group-type="article-subject-classification">
<subject>Nutrition</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Central Nervous System</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Neurological Conditions, Disorders and Treatments</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Toxins, Pollutants and Chemical Agents</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Cellular Physiology</subject>
</subj-group>
<subj-group subj-group-type="overline">
<subject>Original Research</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Protective effects of 1<italic>α</italic>,25‐Dihydroxyvitamin D3 on cultured neural cells exposed to catalytic iron</article-title>
<alt-title alt-title-type="left-running-head">F. Uberti <italic>et</italic> <italic>al</italic>.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="phy212769-cr-0001">
<name>
<surname>Uberti</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="phy212769-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="phy212769-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="phy212769-cr-0002">
<name>
<surname>Morsanuto</surname>
<given-names>Vera</given-names>
</name>
<xref ref-type="aff" rid="phy212769-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="phy212769-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="phy212769-cr-0003">
<name>
<surname>Bardelli</surname>
<given-names>Claudio</given-names>
</name>
<xref ref-type="aff" rid="phy212769-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="phy212769-cr-0004">
<name>
<surname>Molinari</surname>
<given-names>Claudio</given-names>
</name>
<xref ref-type="aff" rid="phy212769-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="phy212769-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Laboratory of Physiology</named-content>
<named-content content-type="organisation-division">Department of Translational Medicine</named-content>
<institution>UPO – University of Eastern Piedmont</institution>
<named-content content-type="city">Novara</named-content>
<country country="IT">Italy</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Francesca Uberti, Department of Translational Medicine, UPO – University of Eastern Piedmont, via Solaroli 17, 28100 Novara, Italy.<break></break>
Tel: +390321660653<break></break>
Fax: +390321620421<break></break>
e‐mail: <email>francesca.uberti@med.uniupo.it</email><break></break></corresp>
<fn fn-type="equal" id="phy212769-note-1001">
<label>†</label>
<p>These authors contributed equally to the study and are co‐first authors.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2016</year>
</pub-date>
<volume>4</volume>
<issue>11</issue>
<issue-id pub-id-type="doi">10.1111/phy2.2016.4.issue-11</issue-id>
<elocation-id>e12769</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 Published by the American Physiological Society and The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. <italic>Physiological Reports</italic> published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:PHY2-4-e12769.pdf" xlink:type="simple"></self-uri>
<abstract id="phy212769-abs-0001">
<title>Abstract</title>
<p>Recent studies have postulated a role for vitamin D and its receptor on cerebral function, and anti‐inflammatory, immunomodulatory and neuroprotective effects have been described; vitamin D can inhibit proinflammatory cytokines and nitric oxide synthesis during various neurodegenerative insults, and may be considered as a potential drug for the treatment of these disorders. In addition, iron is crucial for neuronal development and neurotransmitter production in the brain, but its accumulation as catalytic form (Fe<sup>3+</sup>) impairs brain function and causes the dysregulation of iron metabolism leading to tissue damage due to the formation of toxic free radicals (<styled-content style="fixed-case">ROS</styled-content>). This research was planned to study the role of vitamin D to prevent iron damage in neuroblastoma <styled-content style="fixed-case">BE</styled-content>(2)M17 cells. Mechanisms involved in neurodegeneration, including cell viability, <styled-content style="fixed-case">ROS</styled-content> production, and the most common intracellular pathways were studied. Pretreatment with calcitriol (the active form of vitamin D) reduced cellular injury induced by exposure to catalytic iron.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="phy212769-kwd-0001">Active vitamin D</kwd>
<kwd id="phy212769-kwd-0002">catalytic iron</kwd>
<kwd id="phy212769-kwd-0003">human neuronal cells</kwd>
</kwd-group>
<counts>
<page-count count="11"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>phy212769</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2016</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.1 mode:remove_FC converted:15.06.2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="phy212769-cit-1001" publication-type="journal">
<string-name>
<given-names>F.</given-names>
<surname>Uberti</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Morsanuto</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Bardelli</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Molinari</surname>
</string-name>. <article-title>Protective effects of 1<italic>α</italic>,25‐Dihydroxyvitamin D3 on cultured neural cells exposed to catalytic iron</article-title>. <source/>Physiol Rep, <volume>4</volume> (<issue>11</issue>), <year>2016</year>, e12769, doi: <ext-link ext-link-type="doi" xlink:href="10.14814/phy2.12769">10.14814/phy2.12769</ext-link>
</mixed-citation>
</p>
</notes>
<notes>
<fn-group id="phy212769-ntgp-0001">
<fn fn-type="funding" id="phy212769-note-1002">
<p>Funding Information</p>
<p>No funding information provided.</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<sec id="phy212769-sec-0001">
<title>Introduction</title>
<p>Vitamin D, particularly its active form (calcitriol, 1alpha,25‐dihydroxyvitamin D3), is known for its role in calcium and bone homeostasis, cell proliferation, and modulation of parathyroid hormone secretion (Honmou et al. <xref ref-type="ref" rid="phy212769-bib-0025">2012</xref>). Recently, a number of extraskeletal actions of vitamin D have been reported, including effects on nitric oxide production, antioxidant activity, and endothelial proliferation and migration (Molinari et al. <xref ref-type="ref" rid="phy212769-bib-0035">2011</xref>; Uberti et al. <xref ref-type="ref" rid="phy212769-bib-0058">2014</xref>; Pittarella et al. <xref ref-type="ref" rid="phy212769-bib-0042">2015</xref>). Vitamin D acts on cells and tissues that express a nuclear receptor called VDR. Although in human, most of the vitamin D that ends up in the blood is produced in the kidneys, vitamin D may be synthesized in other tissues such as endothelium, placenta, prostate, skin, colon, breast, and the central nervous system (CNS). The production of vitamin D by these tissues/organs is low compared to the amount produced by kidneys, and this vitamin D is probably not released back into the blood but acts within the tissue where it is made (Garcion et al. <xref ref-type="ref" rid="phy212769-bib-0020">2002</xref>; Tetich et al. <xref ref-type="ref" rid="phy212769-bib-0055">2004</xref>; Cranney et al. <xref ref-type="ref" rid="phy212769-bib-0011">2007</xref>). As regards the CNS, several recent studies have postulated anti‐inflammatory, immunomodulatory, and neuroprotective roles for vitamin D (Garcion et al. <xref ref-type="ref" rid="phy212769-bib-0020">2002</xref>). Both 1alpha‐hydroxylase and VDR are widely expressed in neurons and glial cells, suggesting that vitamin D may have autocrine and paracrine actions in the brain (Prüfer et al. <xref ref-type="ref" rid="phy212769-bib-0044">1999</xref>; Eyles et al. <xref ref-type="ref" rid="phy212769-bib-0016">2005</xref>). VDR is expressed in several regions (Tetich et al. <xref ref-type="ref" rid="phy212769-bib-0055">2004</xref>) of animal (Garcion et al. <xref ref-type="ref" rid="phy212769-bib-0020">2002</xref>) and human (Kalueff et al. <xref ref-type="ref" rid="phy212769-bib-0027">2006</xref>) brains, particularly in the pontine‐midbrain area, cerebellum, thalamus, hypothalamus, basal ganglia, hippocampus, olfactory system and temporal, orbital and cingulate areas of the cortex (Eyles et al. <xref ref-type="ref" rid="phy212769-bib-0015">2003</xref>). Mounting evidence indicates that vitamin D and its receptor have effects that include neuroprotection and immunomodulation (Aloia et al. <xref ref-type="ref" rid="phy212769-bib-0002">2010</xref>). Moreover, vitamin D is a regulator of brain cell proliferation and differentiation, and has an essential role in the brain development (Chopp et al. <xref ref-type="ref" rid="phy212769-bib-0009">2007</xref>; Stewart et al. <xref ref-type="ref" rid="phy212769-bib-0052">2010</xref>) and neurotransmitter synthesis (Tetich et al. <xref ref-type="ref" rid="phy212769-bib-0055">2004</xref>). Vitamin D can exert these effects due to its ability to cross the blood–brain barrier and to bind to VDR within the brain (Chowdhury et al. <xref ref-type="ref" rid="phy212769-bib-0010">2012</xref>; Kienreich et al. <xref ref-type="ref" rid="phy212769-bib-0028">2013</xref>). Upon binding, VDR forms a complex with a retinoid X receptor that controls gene expression (Arbelle et al. <xref ref-type="ref" rid="phy212769-bib-0004">1996</xref>; Thompson et al. <xref ref-type="ref" rid="phy212769-bib-0057">1998</xref>). Gestational vitamin D deficiency induces long‐lasting alterations in the brain structure, including changes in volume, cell proliferation and reduced expression of nerve growth factors, glia‐derived neurotrophic factor, and neurotrophins 3 and 4 (Eyles et al. <xref ref-type="ref" rid="phy212769-bib-0015">2003</xref>; Tetich et al. <xref ref-type="ref" rid="phy212769-bib-0055">2004</xref>; Cui et al. <xref ref-type="ref" rid="phy212769-bib-0012">2007</xref>). Moreover, vitamin D can protect neurons against NMDA, glutamate, 6‐hydroxydopamine, and reactive oxygen species (Brewer et al. <xref ref-type="ref" rid="phy212769-bib-0006">2001</xref>; Ibi et al. <xref ref-type="ref" rid="phy212769-bib-0026">2001</xref>). It has been hypothesized that vitamin D exerts these effects by modulation of neuronal Ca<sup>2+</sup> homeostasis, in particular through downregulation of L‐type voltage‐sensitive Ca<sup>2+</sup> channels in hippocampal neurons against excitotoxic insults (Tetich et al. <xref ref-type="ref" rid="phy212769-bib-0056">2005</xref>), accompanied by an increase in VDR density. Vitamin D can inhibit proinflammatory cytokine and nitric oxide synthesis (Garcion et al. <xref ref-type="ref" rid="phy212769-bib-0019">1997</xref>) induced during various insults or disorders, such as ischemia and reperfusion, Alzheimer's disease, Parkinson's disease, AIDS, infection, multiple sclerosis, and experimental autoimmune encephalomyelitis. For these reasons, it may be considered as a potential treatment of neurodegenerative disorders.</p>
<p>Early vitamin D deficiency may be a risk factor for a number of disorders including schizophrenia, autism (Thompson et al. <xref ref-type="ref" rid="phy212769-bib-0057">1998</xref>; Pilz et al. <xref ref-type="ref" rid="phy212769-bib-0041">2011</xref>; Chowdhury et al. <xref ref-type="ref" rid="phy212769-bib-0010">2012</xref>), multiple sclerosis, Parkinson's disease, and stroke (Sun et al. <xref ref-type="ref" rid="phy212769-bib-0053">2012</xref>). Several neurodegenerative disorders have been associated with the dysregulation of iron metabolism (Ponka <xref ref-type="ref" rid="phy212769-bib-0043">2004</xref>) including Huntington's disease, Parkinson's disease, and neurodegeneration with iron accumulation (Mena et al. <xref ref-type="ref" rid="phy212769-bib-0034">2015</xref>). Iron is involved in a wide range of cellular processes, including DNA synthesis and repair, energy metabolism, phospholipids metabolism, and oxidative phosphorylation (Salvador <xref ref-type="ref" rid="phy212769-bib-0046">2010</xref>; Park et al. <xref ref-type="ref" rid="phy212769-bib-0039">2015</xref>). In addition, iron is crucial for neuronal development and neurotransmitter production in the brain (Sipe et al. <xref ref-type="ref" rid="phy212769-bib-0049">2002</xref>; Park et al. <xref ref-type="ref" rid="phy212769-bib-0039">2015</xref>). However, the accumulation of iron as catalytic form (Fe<sup>3+</sup>) impairs the brain function, and dysregulation of iron metabolism results in tissue damage due to the formation of toxic free radicals (ROS) (Lipinski <xref ref-type="ref" rid="phy212769-bib-0032">2011</xref>; Urrutia et al. <xref ref-type="ref" rid="phy212769-bib-0060">2014</xref>; Park et al. <xref ref-type="ref" rid="phy212769-bib-0039">2015</xref>). Neurons have highly regulated mechanisms for controlling cellular iron levels. The uptake is controlled by transferrin receptor‐1 or by divalent metal transporter‐1 (DMT1; Moos et al. <xref ref-type="ref" rid="phy212769-bib-0036">2007</xref>; Dev et al. <xref ref-type="ref" rid="phy212769-bib-0014">2015</xref>). The uptaken iron is stored within ferritin to avoid iron‐mediated damage and preserved for other cellular activities (Hentze and Kuhn <xref ref-type="ref" rid="phy212769-bib-0022">1996</xref>; Rouault and Cooperman <xref ref-type="ref" rid="phy212769-bib-0045">2006</xref>; Andrews and Schmidt <xref ref-type="ref" rid="phy212769-bib-0003">2007</xref>; Dev et al. <xref ref-type="ref" rid="phy212769-bib-0014">2015</xref>). Cells also control iron levels by releasing it through ferroportin (Abboud and Haile <xref ref-type="ref" rid="phy212769-bib-0001">2000</xref>; Hentze et al. <xref ref-type="ref" rid="phy212769-bib-0023">2004</xref>; Dev et al. <xref ref-type="ref" rid="phy212769-bib-0014">2015</xref>). Inappropriate regulation of one of these mechanisms may result in accumulation of iron. Neurons cannot reduce intracellular iron by cell division, so iron concentration control depends on cellular iron homeostasis. Although iron content increases with age (Zecca et al. <xref ref-type="ref" rid="phy212769-bib-0062">2001</xref>; Gotz et al. <xref ref-type="ref" rid="phy212769-bib-0021">2004</xref>; Mura et al. <xref ref-type="ref" rid="phy212769-bib-0037">2006</xref>), a large portion of neuronal cells stay viable and control the degree of oxidative damage, presumably through the activation of adaptive mechanisms (Mura et al. <xref ref-type="ref" rid="phy212769-bib-0037">2006</xref>).</p>
<p>Neuronal iron accumulation is thought to be involved in several neurodegenerative disorders, but the molecular events underlying the toxicity remain unknown. Recently, a relationship between iron and vitamin D has been observed, especially in the context of iron deficiency and anemia (Lee et al. <xref ref-type="ref" rid="phy212769-bib-0031">2009</xref>). Moreover, a neuroprotective effect of vitamin D against iron‐induced oxidative injury in locus coeruleus of rat has been reported (Chen et al. <xref ref-type="ref" rid="phy212769-bib-0008">2003</xref>).</p>
<p>However, little is known about its role in counteracting the harmful effects of intraneuronal iron accumulation.</p>
<p>The present research was planned to study the effects of vitamin D on iron accumulation after 6 days of stimulation in BE(2)M17 neuroblastoma cells. (Filograna et al. <xref ref-type="ref" rid="phy212769-bib-0017">2015</xref>). Mechanisms involved in neurodegeneration, such as cell viability, ROS production, and the most common intracellular pathways were studied.</p>
</sec>
<sec id="phy212769-sec-0002">
<title>Material and Methods</title>
<sec id="phy212769-sec-0003">
<title>Cell culture</title>
<p>Human neuroblastoma BE(2)‐M17 cells were cultured as previously described (Filograna et al. <xref ref-type="ref" rid="phy212769-bib-0017">2015</xref>) in a 1:1 mixture of Ham's F12 and Dulbecco's Modified Eagle's Medium (Sigma‐Aldrich, Milan) supplemented with 10% fetal bovine serum (FBS, Sigma‐Aldrich, Milan), 1% penicillin/Streptomycin (Sigma‐Aldrich, Milan), and grown in the presence of 5% CO2 in an incubator at 37°C. In all experiments, cells were used at early passages (P1‐5 after purchase from LGC standards). To study cell viability (MTT test) and ROS production, 1 × 10<sup>4</sup> cells were plated on 96‐well plates; to perform iron staining (Perl's and Turnbull), immunocytochemistry and immunofluorescence studies, 0.25 × 10<sup>4</sup> cells were placed in CultureSlide (BD, Bedford, MA) with four chambers; to analyze the intracellular pathways through western blot analysis, cells were plated on 60‐mm culture dishes until confluence.</p>
</sec>
<sec id="phy212769-sec-0004">
<title>Experimental protocol</title>
<p>BE(2)M17 cells were treated with different concentrations of catalytic iron (Fe<sup>3+</sup>) in a range (from 75 to 300 μmol/L) that was able to induce neurodegeneration (Park et al. <xref ref-type="ref" rid="phy212769-bib-0039">2015</xref>). The same stimulations were replicated after pretreatment with calcitriol in a range (0.1–100 nmol/L) reported in literature (Bini et al. <xref ref-type="ref" rid="phy212769-bib-0005">2012</xref>) as causing no significant change in cell viability. Before stimulation, cells were synchronized overnight in serum‐free medium and incubated in the culture medium without red‐phenol supplemented with 5% FBS, 1% penicillin/streptomycin, before and during treatment. Stimulation with 1 nM calcitriol was maintained for 6 days and replicated as pretreatment for 6 days before stimulation with catalytic iron for another 6 days.</p>
</sec>
<sec id="phy212769-sec-0005">
<title>Iron staining</title>
<p>Perls’ stain was used to visualize, respectively, ferric iron (Fe<sup>3+</sup>) and ferrous iron (Fe<sup>2+</sup>) in BE(2)M17 cells as reported in the literature (Meguro et al. <xref ref-type="ref" rid="phy212769-bib-0033">2007</xref>; Dang et al. <xref ref-type="ref" rid="phy212769-bib-0013">2011</xref>; Owen et al. <xref ref-type="ref" rid="phy212769-bib-0038">2016</xref>). Cells cultured in chamber slide, as described before, were washed three times with cold PBS 1× supplemented with 2 mmol/L sodium orthovanadate, and fixed using a cold fixative solution (3.7% formaldehyde, 3% sucrose in PBS 1×) for 20 min at RT. Slides to be stained for Fe<sup>3+</sup> were incubated with potassium ferrocyanide, then with potassium ferrocyanide + HCl, for 30 min each (Perls’ method). Finally, they were counterstained with safranin‐O and mounted with Bio Mount (Bio‐Otika, Milan, Italy). The intensity of Perls’ staining was semiquantified from five photomicrographs per chamber (Owen et al. <xref ref-type="ref" rid="phy212769-bib-0038">2016</xref>). All micrographs were taken at the same magnification. Luminosity signals were determined using ImagePro 3 software (NIH, Bethesda, US), and the results were expressed as means ± SD (%).</p>
</sec>
<sec id="phy212769-sec-0006">
<title>MTT test</title>
<p>MTT dye (Sigma‐Aldrich) was used to determine cell viability. After stimulation, cells were incubated with 1% MTT dye for 2 h at 37°C in an incubator as previously described (Uberti et al. <xref ref-type="ref" rid="phy212769-bib-0058">2014</xref>; Lattuada et al. <xref ref-type="ref" rid="phy212769-bib-0030">2015</xref>). The purple formazan crystals (3‐[4,5‐dimethylthiazol‐2‐y1]‐2,5‐ diphenyltetrazoliumbromide) were dissolved in DMSO. Cell viability was determined by measuring the absorbance through a spectrometer (VICTORX3 Multilabel Plate Reader) at 570 nm with correction at 690 nm, and cell viability calculated by comparing results to control cells (100% viable).</p>
</sec>
<sec id="phy212769-sec-0007">
<title>ROS production</title>
<p>The rate of superoxide anion release was used to examine the effects of calcitriol against the oxidative stress induced by catalytic iron. Superoxide anion production was measured as superoxide dismutase‐inhibitable reduction of cytochrome C, as previously described (Uberti et al. <xref ref-type="ref" rid="phy212769-bib-0058">2014</xref>). In all samples (both stimulated and untreated), 100 <italic>μ</italic>L of cytochrome C was added, and in one group, 100 <italic>μ</italic>L of superoxide dismutase was also added for 30 min in the incubator (all substances from Sigma‐Aldrich). The absorbance changes in the sample supernatants were measured at 550 nm in a spectrometer (VICTORX3 Multilabel Plate Reader). O2 was expressed as nanomoles per reduced cytochrome C per microgram of protein, using an extinction coefficient of 21,000 mL/cm, after interference absorbance subtraction (Lattuada et al. <xref ref-type="ref" rid="phy212769-bib-0030">2015</xref>).</p>
</sec>
<sec id="phy212769-sec-0008">
<title>Western Blot for ferritin, VDR, p53, c‐Myc, Ki67, and ERK<sup>1/2</sup>/MAPK</title>
<p>Cells were washed and then lysed in ice with Complete Tablet buffer (Roche) supplemented with 2 mmol/L sodium orthovanadate, and 1:1000 phenylmethanesulfonylfluoride (PMSF; Sigma‐Aldrich). A quantity of 35 <italic>μ</italic>g of protein from each lysate was loaded on 15 or 5% SDS‐PAGE gels and transferred to polyvinylidene fluoride membranes (PVDF, GE Healthcare Europe GmbH, Milan, Italy). They were incubated overnight at 4°C with specific primary antibody: anti‐ferritin (1:250, Santa‐Cruz), anti‐VDR (D‐6) (1:200, Santa‐Cruz), anti‐p53 (1:500, Santa‐Cruz), anti‐cMyc (1:200, Millipore S.p.A., Milan, Italy), anti‐Ki67 (1:500, Santa‐Cruz), anti‐Phospho‐p44/42 MAPK (Thr202/Tyr204, 1:1000 Cell‐Signaling). Protein expression was normalized and verified through ß‐actin detection (1:5000; Sigma, Milan, Italy).</p>
</sec>
<sec id="phy212769-sec-0009">
<title>c‐Myc, Ki67 immunocytochemistry</title>
<p>Cells, fixed as described above, were washed twice with cold PBS 1X, permeabilized with cold PBS 1× with cold 0.5% Triton X‐100 on ice at 4°C for 20 min and washed with PBS 1×. Then, the chamber slides were incubated with 3% hydrogen peroxide in PBS 1× for 8 min to block endogenous peroxidase activity and maintained in a blocking solution composed of PBS 1× with 3% albumin from bovine serum (BSA, Sigma, Milan, Italy) for 1 h at room temperature. The slides were incubated overnight at 4°C with specific primary antibody: 1:50 c‐Myc, 1:50 Ki67. All antibodies were diluted in PBS 1× in a humidified chamber and then incubated for 20 min with diluted biotinylated secondary antibody solution (Dako Italia, Milan, Italy) and then for 20 min with VECTASTAIN<sup>®</sup> ABC Reagent (Dako Italia, Milan, Italy). Finally, sections were washed, incubated with peroxidase substrate solution until the desired stain intensity had developed (Peroxidase/DAB, Dako Italia, Milan, Italy), rinsed in tap water, counterstained with Mayer's hematoxylin, and mounted with Bio Mount (Bio‐Optica, Milan, Italy). The number of positive cells was calculated as described elsewhere (Lee et al. <xref ref-type="ref" rid="phy212769-bib-0031">2009</xref>); briefly, 12 different areas (1 mm<sup>2</sup>) randomly selected from each section were taken, and the number of signals was determined using ImagePro 3 software (NIH, Bethesda, US). The results were expressed as a means ± SD (%).</p>
</sec>
<sec id="phy212769-sec-0010">
<title>p53 immunofluorescence</title>
<p>Cells, fixed as described above, were washed with cold PBS 1X, permeabilized with cold PBS 1× with 0.5% Triton X‐100 for 20 min at 4°C, incubated in blocking solution (1% BSA and 5% FBS in PBS 1X) for 30 min at RT and then treated with p53 specific antibody (1:50, Santa‐ Cruz) in PBS 1× overnight at 4°C. The slides were then incubated with fitch‐secondary antibodies (1:200, Sigma‐Aldrich) in PBS 1× for 1 h in the dark, counterstained with DAPI (1 <italic>μ</italic>g/mL; Sigma‐ Aldrich) diluted in PBS 1× for 5 min in the dark at room temperature and finally mounted in Vectashield (D.B.A. Italia). The number of positive cells was calculated as described by Lee et al. (<xref ref-type="ref" rid="phy212769-bib-0031">2009</xref>): briefly, 12 different areas (1 mm<sup>2</sup>) randomly selected from each section were taken, and the number of signals was determined using ImagePro 3 software (NIH, Bethesda, US). The results were expressed as means ± SD (%).</p>
</sec>
<sec id="phy212769-sec-0011">
<title>Statistical analysis</title>
<p>For each experimental protocol, at least four independent experiments were run; the results are expressed as means ± SD of four technical replicates. One‐way ANOVA followed by Bonferroni post hoc test was used for statistical analysis, and pairwise differences compared by Mann‐Whitney U tests. <italic>P</italic>‐values &lt;0.05 were considered statistically significant.</p>
</sec>
</sec>
<sec id="phy212769-sec-0012">
<title>Results</title>
<sec id="phy212769-sec-0013">
<title>Cell viability and reactive oxygen species (ROS) production in neuroblastoma cells</title>
<p>The effect of calcitriol was analyzed by the stimulation of BE(2)M17 cultures with different doses (from 0.01 to 100 nmol/L, dissolved in ethanol) measuring cell viability through MTT test after 6 days. As illustrated in a dose–response study (Fig. <xref ref-type="fig" rid="phy212769-fig-0001">1</xref>A), after 6 days, the effect of calcitriol was concentration‐dependent, with a minimally effective dose of 1 nmol/L (−0.17 ± 1.89% vs. control). This concentration was used for all successive experiments. The effect of the solvent of calcitriol was also tested.</p>
<fig fig-type="Figure" id="phy212769-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Effects of calcitriol (cal) on cell viability and <styled-content style="fixed-case">ROS</styled-content> production. (A) dose–response study of vitamin D (0.01–100 nmol/L) on viability of <styled-content style="fixed-case">BE</styled-content>(2)M17 cells. cal = calcitriol; <styled-content style="fixed-case">ET</styled-content>‐<styled-content style="fixed-case">OH</styled-content> = ethanol. *<italic>P</italic> &lt; 0.05 versus control. (B) <styled-content style="fixed-case">MTT</styled-content> test in cells treated with catalytic iron (75–300 μmol/L) alone for 6 days or pretreated with 1 nmol/L calcitriol for 6 days. a, b, c, e, f versus control (0%); b, c, e <italic>P </italic>&lt;<italic> </italic>0.05 versus a; a, c, f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; a, b, c <italic>P </italic>&lt;<italic> </italic>0.05 versus c; e, f, g <italic>P </italic>&lt;<italic> </italic>0.05 versus d; e, f <italic>P </italic>&lt;<italic> </italic>0.05 versus g. (C) <styled-content style="fixed-case">ROS</styled-content> production (expressed as cytochrome C reduced per <italic>μ</italic>g of protein) in cells treated with catalytic iron (75–300 μmol/L) alone for 6 days or pretreated with 1 nmol/L calcitriol for 6 days. b, c, d, e, g <italic>P </italic>&lt;<italic> </italic>0.05 versus a; g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus f; g <italic>P </italic>&lt;<italic> </italic>0.05 versus h; c, d <italic>P </italic>&lt;<italic> </italic>0.05 versus e; c <italic>P </italic>&lt;<italic> </italic>0.05 versus d. In both panels, results are expressed as means ± <styled-content style="fixed-case">SD</styled-content> (%) of four technical replicates normalized to control values.</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="PHY2-4-e12769-g001"></graphic>
</fig>
<p>The influence of calcitriol on the effects of Fe<sup>3+</sup> on the viability of BE(2)M17 cells was studied. As shown in Figure <xref ref-type="fig" rid="phy212769-fig-0001">1</xref>B, catalytic iron alone decreased cell viability in a concentration and time‐dependent manner, confirming data reported previously (Park et al. <xref ref-type="ref" rid="phy212769-bib-0039">2015</xref>). A maximal reduction was observed in the presence of 300 μmol/L Fe<sup>3+</sup> (−31.5 ± 3.9% vs. control, <italic>P</italic> &lt; 0.05). Pretreatment with calcitriol counteracted the decrease on cell viability induced by catalytic iron in a dose‐dependent manner and the maximum effect, of about 90% was observed in the presence of 300 μmol/L calcitriol (<italic>P</italic> &lt; 0.05 vs. catalytic iron alone).</p>
<p>The same conditions were reproduced to analyze ROS production in BE(2)M17 cells (Fig. <xref ref-type="fig" rid="phy212769-fig-0001">1</xref>C). In cells treated with calcitriol alone, no significant release of ROS into the cell medium was observed demonstrating that the treatment did not lead to cell death. On the contrary, in cells treated with catalytic iron alone, there was a significant dose‐dependent increase in ROS production (Fig. <xref ref-type="fig" rid="phy212769-fig-0001">1</xref>C, <italic>P</italic> &lt; 0.05). The maximum effect was obtained by 300 μmol/L (114.6 ± 1.84 of cytochrome C reduced per <italic>μ</italic>g of protein). Pretreatment with calcitriol was able to counteract the ROS production induced by catalytic iron and this effect was more evident in the presence of 150 μmol/L calcitriol (21.1 ± 2.5 cytochrome C reduced per <italic>μ</italic>g of protein; <italic>P</italic> &lt; 0.05) and 300 μmol/L Fe<sup>3+</sup> (13.6 ± 2.8 cytochrome C reduced per <italic>μ</italic>g of protein; <italic>P</italic> &lt; 0.05) compared to catalytic iron alone (47.4 ± 1.86 and 114.6 ± 1.84 cytochrome C reduced per <italic>μ</italic>g of protein, respectively; <italic>P</italic> &lt; 0.05). These data demonstrate the ability of calcitriol to prevent the negative effects of oxidative stress caused by catalytic iron on neural cells.</p>
</sec>
<sec id="phy212769-sec-0014">
<title>Analysis of iron accumulation after 6 days of treatment with catalytic iron</title>
<p>Perls's stain for ferric iron (catalytic) was used to study the involvement of vitamin D in preventing iron accumulation. Calcitriol alone did not influence Perls's stain compared to control (<italic>P</italic> &gt; 0.05; Fig. <xref ref-type="fig" rid="phy212769-fig-0002">2</xref>). On the contrary, in neuroblastoma cells treated with different concentrations of catalytic iron, a dose‐dependent accumulation of Fe<sup>3+</sup> was observed. The maximum effect was observed in the presence of 300 μmol/L Fe<sup>3+</sup> and the highest concentration was observed in the perinuclear regions of living cells. Pretreatment with calcitriol was able to modulate this accumulation. Indeed, the number of positive cells significantly decreased (of about 65%; <italic>P</italic> &lt; 0.05) compared to catalytic iron treatment alone.</p>
<fig fig-type="Figure" id="phy212769-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>Perl's staining to visualize ferric iron accumulation after pretreatment for 6 days with 1 nmol/L calcitriol (cal) and treatment with Fe<sup>3+</sup> (from 75 to 300 μmol/L) for 6 days on <styled-content style="fixed-case">BE</styled-content>(2)M17 cells. Representative pictures reported were an example of four technical replicates taken by microscopy at original magnification ×40. The scale bar (50 μmol/L) in the first image is valid for all pictures. The ratio reported is a mean (±<styled-content style="fixed-case">SD</styled-content>) (%) of positive cells counted in 12 different areas. b, c, d, f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; c, d, f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d; f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus e; f, g <italic>P </italic>&lt;<italic> </italic>0.05 versus h; g <italic>P </italic>&lt;<italic> </italic>0.05 versus h.</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="PHY2-4-e12769-g002"></graphic>
</fig>
<p>To confirm these data, ferritin, a protein involved in iron storage, was measured by western blot (Fig. <xref ref-type="fig" rid="phy212769-fig-0003">3</xref>). Ferritin, the main iron storage protein in mammalian cells, is considered to be the first line of defense against iron overload. Exposure to increasing concentrations of catalytic iron from 75 to 300 μmol/L caused a significant increase in cell ferritin content (Fig. <xref ref-type="fig" rid="phy212769-fig-0003">3</xref>). At 300 μmol/L extracellular Fe<sup>3+</sup>, ferritin showed a tripled increase (<italic>P</italic> &lt; 0.05 vs. control). On a molar basis, ferritin produced a greater increase than catalytic iron. Pretreatment with calcitriol prevented this increase in ferritin expression: at 300 μmol/L, ferritin doubled (<italic>P</italic> &lt; 0.05) compared to control. These data confirmed the observations described in Figure <xref ref-type="fig" rid="phy212769-fig-0002">2</xref> on the protective effects of calcitriol against damage depending on iron accumulation.</p>
<fig fig-type="Figure" id="phy212769-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>Ferritin studies by western blot and densitometric analysis after pretreatment of <styled-content style="fixed-case">BE</styled-content>(2)M17 cells for 6 days with 1 nmol/L calcitriol (cal) and treatment with Fe<sup>3+</sup> (from 75 to 300 μmol/L) for 6 days. Protein extracts were analyzed by immunoblotting with specific antibodies against the indicated proteins; results are expressed as means ± <styled-content style="fixed-case">SD</styled-content> (%) normalized to control values of four technical replicates; b, c, d, f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; d, g <italic>P </italic>&lt;<italic> </italic>0.05 versus c; f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus e; g <italic>P </italic>&lt;<italic> </italic>0.05 versus f.</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="PHY2-4-e12769-g003"></graphic>
</fig>
</sec>
<sec id="phy212769-sec-0015">
<title>Study of the intracellular pathways activated by calcitriol</title>
<p>The presence of VDR receptors in neuroblastoma cells was studied by western blot and densitometric analysis (Fig. <xref ref-type="fig" rid="phy212769-fig-0004">4</xref>A). The protein expression was augmented compared to control (about 50%, <italic>P</italic> &lt; 0.05) in the presence of calcitriol alone, demonstrating that calcitriol may exert its effects by VDR receptor signaling. The samples treated with Fe<sup>3+</sup> did not induce a significant change in VDR expression, but in samples pretreated with calcitriol, an increase in VDR expression was observed compared to control, indicating the possible involvement of VDR in the protective effects exerted by calcitriol. In this context, the role of MAPK, a marker of cell proliferation, was examined. In samples treated with calcitriol alone, the activation of ERK was similar to control, confirming data obtained from MTT test on the ineffective dose of calcitriol (Fig. <xref ref-type="fig" rid="phy212769-fig-0004">4</xref>B). In samples treated with catalytic iron alone, the activation of ERK was overexpressed in a dose‐dependent manner, suggesting that iron‐dependent generation of ROS activates the ERK/MAPK pathway. On the other hand, pretreatment with calcitriol attenuated the overexpression caused by catalytic iron (<italic>P</italic> &lt; 0.05).</p>
<fig fig-type="Figure" id="phy212769-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<p>Western blot and densitometric analysis after pretreatment of <styled-content style="fixed-case">BE</styled-content>(2)M17 cells for 6 days with 1 nmol/L calcitriol (cal) and treatment with catalytic iron (75–300 μmol/L) for 6 days. Results are expressed as means ± <styled-content style="fixed-case">SD</styled-content> (%) normalized to control values of four technical replicates. (A) shows western blot of protein extracts analyzed by immunoblotting with a specific antibody against <styled-content style="fixed-case">VDR</styled-content> and densitometric analysis of <styled-content style="fixed-case">VDR</styled-content>. d, e, f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; g <italic>P </italic>&lt;<italic> </italic>0.05 versus e; f, h <italic>P </italic>&lt;<italic> </italic>0.05 versus g; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d; g <italic>P </italic>&lt;<italic> </italic>0.05 versus c. (B) shows western blot of protein extracts analyzed by immunoblotting with a specific antibody against p‐<styled-content style="fixed-case">ERK</styled-content> and densitometric analysis of p‐<styled-content style="fixed-case">ERK</styled-content>. b, c, d, e, d, f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; c, d, f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; d, g, <italic>P </italic>&lt;<italic> </italic>0.05 versus c; g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus e; g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus f; h <italic>P </italic>&lt;<italic> </italic>0.05 versus g; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d.</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="PHY2-4-e12769-g004"></graphic>
</fig>
</sec>
<sec id="phy212769-sec-0016">
<title>Analysis of the neurodegenerative markers: p‐53, Ki67, c‐myc</title>
<p>p53, Ki67, and c‐Myc expressions were investigated by western blot and densitometric analysis in BE(2)M17 cells treated with the same agents and under the same conditions as previously reported. Calcitriol alone had no significant effect on these markers (Fig. <xref ref-type="fig" rid="phy212769-fig-0005">5</xref>). In the presence of catalytic iron, dose‐dependent activations p53, Ki67, and c‐Myc were observed (Fig. <xref ref-type="fig" rid="phy212769-fig-0005">5</xref>), and maximum effects were observed with 300 μmol/L Fe<sup>3+</sup> after 6 days of treatment (3, 10, and 1.5 fold activation, respectively, vs. control values). Similar data were observed in immunofluorescence (p53) and immunocytochemistry experiments (Ki67, c‐Myc; Fig. <xref ref-type="fig" rid="phy212769-fig-0006">6</xref>). Pretreatment with calcitriol for 6 days counteracted the iron‐induced activation of p53, Ki67, and c‐Myc (Figs <xref ref-type="fig" rid="phy212769-fig-0005">5</xref> and <xref ref-type="fig" rid="phy212769-fig-0006">6</xref>). These effects were more evident in samples treated with 300 μmol/L Fe<sup>3+</sup> (0.9, 1, and 0 fold of activation, respectively).</p>
<fig fig-type="Figure" id="phy212769-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<p>Western blot and densitometric analysis after pretreatment of <styled-content style="fixed-case">BE</styled-content>(2)M17 cells for 6 days with 1 nmol/L calcitriol (cal) and treatment with catalytic iron (75–300 μmol/L) for 6 days. The results are expressed as means ± <styled-content style="fixed-case">SD</styled-content> (%) normalized to control values of four technical replicates (A) shows western blot of protein extracts analyzed by immunoblotting with a specific antibody against p53 and densitometric analysis of p53. b, c, d, f, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; c, d, f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; d, g <italic>P </italic>&lt;<italic> </italic>0.05 versus c; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d; f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus e; g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus f; h <italic>P </italic>&lt;<italic> </italic>0.05 versus g. (B) shows western blot of protein extracts analyzed by immunoblotting with a specific antibody against ki67 and densitometric analysis of ki67. b, c, d, f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus e; c, d, f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; d, g <italic>P </italic>&lt;<italic> </italic>0.05 versus c; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d; g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus f; h <italic>P </italic>&lt;<italic> </italic>0.05 versus g. (C) shows western blot of protein extracts analyzed by immunoblotting with a specific antibody against c‐Myc and densitometric analysis of c‐Myc. b, c, d <italic>P </italic>&lt;<italic> </italic>0.05 versus a; c, d, f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; d, g <italic>P </italic>&lt;<italic> </italic>0.05 versus c; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d; f <italic>P </italic>&lt;<italic> </italic>0.05 versus e.</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="PHY2-4-e12769-g005"></graphic>
</fig>
<fig fig-type="Figure" id="phy212769-fig-0006" orientation="portrait" position="float" xml:lang="en">
<label>Figure 6</label>
<caption>
<p>Analysis of positivity of cells by immunofluorescence and immunocytochemistry in BE(2)M17 cells pretreated for 6 days with 1 nmol/L calcitriol (cal) and treated with catalytic iron (75–300 μmol/L) for 6 days. Data are expressed as means (±SD) of positive cells counted in 12 different areas in percentage obtained by four technical replicates. (A) shows p53 positive cells. b, c, d, f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; c, d, f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; d, g <italic>P </italic>&lt;<italic> </italic>0.05 versus c; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d; f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus e; g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus f; h <italic>P </italic>&lt;<italic> </italic>0.05 versus g. (B) shows the ratio of ki67 positive cells. b, c, d, e, f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; f <italic>P </italic>&lt;<italic> </italic>0.05 versus b; g <italic>P </italic>&lt;<italic> </italic>0.05 versus c; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d; f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus e; g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus f; h <italic>P </italic>&lt;<italic> </italic>0.05 versus g. (C) shows the ratio of c‐Myc positive cells. b, c, d, f, g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus a; c, d, f, <italic>P </italic>&lt;<italic> </italic>0.05 versus b; g <italic>P </italic>&lt;<italic> </italic>0.05 versus c; h <italic>P </italic>&lt;<italic> </italic>0.05 versus d; f, g <italic>P </italic>&lt;<italic> </italic>0.05 versus e; g, h <italic>P </italic>&lt;<italic> </italic>0.05 versus f.</p>
</caption>
<graphic id="nlm-graphic-13" xlink:href="PHY2-4-e12769-g006"></graphic>
</fig>
</sec>
</sec>
<sec id="phy212769-sec-0017">
<title>Discussion</title>
<p>Although iron is an essential element, its intraneuronal accumulation can be toxic due to its capability of switching between ferrous and ferric states. The latter impairs iron metabolism, leading to neurodegenerative disorders including Alzheimer's and Parkinson's diseases (Smith et al. <xref ref-type="ref" rid="phy212769-bib-0051">1997</xref>; Takanashi et al. <xref ref-type="ref" rid="phy212769-bib-0054">2001</xref>).</p>
<p>As regards the mechanism of iron‐induced neuronal damage, it has been hypothesized that iron acquired by neurons accumulates in mitochondria. Neuronal death is preceded by the change in the mitochondria morphology, from a continuous to a fragmented profile, and by the loss of the mitochondrial membrane potential (Pelizzoni et al. <xref ref-type="ref" rid="phy212769-bib-0040">2011</xref>; Park et al. <xref ref-type="ref" rid="phy212769-bib-0039">2015</xref>). Another important factor implicated in mitochondrial fragmentation is the oxidative stress, also associated with several neurodegenerative disorders (Urrutia et al. <xref ref-type="ref" rid="phy212769-bib-0059">2013</xref>; Singh et al. <xref ref-type="ref" rid="phy212769-bib-0048">2014</xref>; Dev et al. <xref ref-type="ref" rid="phy212769-bib-0014">2015</xref>). Iron‐associated oxidative stress is due to its participation in the Fenton reaction, which generates ROS and consequently induces irreversible damage to DNA, RNA, proteins, and lipids (Urrutia et al. <xref ref-type="ref" rid="phy212769-bib-0060">2014</xref>). In this context, a relationship between iron, oxidative stress, and neuronal loss has been established (Gao et al. <xref ref-type="ref" rid="phy212769-bib-0018">2009</xref>; Salvador and Oteiza <xref ref-type="ref" rid="phy212769-bib-0047">2011</xref>). To reduce iron damage in the brain, Chen et al. (<xref ref-type="ref" rid="phy212769-bib-0008">2003</xref>) first suggested a possible use of vitamin D supplementation, after reporting that systemic administration of vitamin D attenuates iron‐induced oxidative injuries in the rat locus coeruleus. Thus, there is evidence that the neuroprotective action of vitamin D involves neuronal calcium regulation, antioxidative pathway, immunomodulation, and detoxification.</p>
<p>This study demonstrates that calcitriol can prevent Fe<sup>3+</sup>‐dependent oxidative injury in a neuronal cell line. The beneficial effect consists in decrease in iron accumulation and ROS production, two co‐factors of neurodegeneration (Cantu et al. <xref ref-type="ref" rid="phy212769-bib-0007">2009</xref>). In addition, the observed effects of calcitriol in BE(2)M17 cells involved the activation of VDR receptor. Moreover, under our conditions, the survival pathway (ERKs) in the presence of calcitriol was also activated. In addition, Fe<sup>3+</sup>‐dependent activation of the neurodegenerative biomarkers p53 (Herold et al. <xref ref-type="ref" rid="phy212769-bib-0024">2015</xref>), Ki67 (Wharton et al. <xref ref-type="ref" rid="phy212769-bib-0061">2005</xref>) and c‐Myc (Sleiman et al. <xref ref-type="ref" rid="phy212769-bib-0050">2011</xref>), was confirmed.</p>
<p>In conclusion, the results described in this work highlight that calcitriol can protect cultured BE(2)M17 cells against Fe<sup>3+</sup>‐related oxidative stress and iron accumulation. The results support the potential use of vitamin D supplementation as a therapeutic strategy in neurodegeneration disorders.</p>
</sec>
<sec id="phy212769-sec-0019">
<title>Conflict of Interest</title>
<p>None declared.</p>
</sec>
</body>
<back>
<ack id="phy212769-sec-0018">
<title>Acknowledgments</title>
<p>The authors thank Ms Mariangela Fortunato for her precious help with the preparation of the article.</p>
</ack>
<ref-list content-type="cited-references" id="phy212769-bibl-0001">
<title>References</title>
<ref id="phy212769-bib-0001">
<mixed-citation id="phy212769-cit-0001" publication-type="journal">
<string-name>
<surname>Abboud</surname>, <given-names>S.</given-names>
</string-name>, and <string-name>
<given-names>D. J.</given-names>
<surname>Haile</surname>
</string-name>. <year>2000</year>
<article-title>A novel mammalian iron‐regulated protein involved in intracellular iron metabolism</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>:<fpage>19906</fpage>–<lpage>19912</lpage>.<pub-id pub-id-type="pmid">10747949</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0002">
<mixed-citation id="phy212769-cit-0002" publication-type="journal">
<string-name>
<surname>Aloia</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Bojadzievski</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Yusupov</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Shahzad</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Pollach</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Mikhail</surname>
</string-name>, et al. <year>2010</year>
<article-title>The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double‐blind, placebo‐controlled parallel group, longitudinal factorial design</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>95</volume>:<fpage>3216</fpage>–<lpage>3224</lpage>.<pub-id pub-id-type="pmid">20463100</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0003">
<mixed-citation id="phy212769-cit-0003" publication-type="journal">
<string-name>
<surname>Andrews</surname>, <given-names>N. C.</given-names>
</string-name>, and <string-name>
<given-names>P. J.</given-names>
<surname>Schmidt</surname>
</string-name>. <year>2007</year>
<article-title>Iron homeostasis</article-title>. <source/>Annu. Rev. Physiol.
<volume>69</volume>:<fpage>69</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">17014365</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0004">
<mixed-citation id="phy212769-cit-0004" publication-type="journal">
<string-name>
<surname>Arbelle</surname>, <given-names>J. E.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Gaead</surname>
</string-name>, <string-name>
<given-names>E. A.</given-names>
<surname>Allegretto</surname>
</string-name>, <string-name>
<given-names>J. W.</given-names>
<surname>Pike</surname>
</string-name>, and <string-name>
<given-names>J. S.</given-names>
<surname>Adams</surname>
</string-name>. <year>1996</year>
<article-title>Inhibition of vitamin D receptor‐retinoid X receptor‐vitamin D response element complex formation by nuclear extracts of vitamin D‐ resistant new world primate cells</article-title>. <source/>Endocrinology
<volume>137</volume>:<fpage>786</fpage>–<lpage>789</lpage>.<pub-id pub-id-type="pmid">8593831</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0005">
<mixed-citation id="phy212769-cit-0005" publication-type="journal">
<string-name>
<surname>Bini</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Frati</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Garcia‐Gil</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Battistini</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Granado</surname>
</string-name>, <string-name>
<given-names>M.</given-names> <surname>Martinesi</surname>
</string-name>, et al. <year>2012</year>
<article-title>New signalling pathway involved in the anti‐proliferative action of vitamin D<sub>3</sub> and its analogues in human neuroblastoma cells. A role for ceramide kinase</article-title>. <source/>Neuropharmacology
<volume>63</volume>:<fpage>524</fpage>–<lpage>537</lpage>.<pub-id pub-id-type="pmid">22579669</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0006">
<mixed-citation id="phy212769-cit-0006" publication-type="journal">
<string-name>
<surname>Brewer</surname>, <given-names>L. D.</given-names>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Thibault</surname>
</string-name>, <string-name>
<given-names>K. C.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Langub</surname>
</string-name>, <string-name>
<given-names>P. W.</given-names>
<surname>Landfield</surname>
</string-name>, and <string-name>
<given-names>N. M.</given-names>
<surname>Porter</surname>
</string-name>. <year>2001</year>
<article-title>Vitamin D hormone confers neuroprotection in parallel with downregulation of l‐type calcium channel expression in hippocampal neurons</article-title>. <source/>J. Neurosci.
<volume>21</volume>:<fpage>98</fpage>–<lpage>108</lpage>.<pub-id pub-id-type="pmid">11150325</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0007">
<mixed-citation id="phy212769-cit-0007" publication-type="journal">
<string-name>
<surname>Cantu</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Schaack</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Patel</surname>
</string-name>. <year>2009</year>
<article-title>Oxidative inactivation of mitochondrial aconitase results in iron and H2O2‐mediated neurotoxicity in rat primary mesencephalic cultures</article-title>. <source/>PLoS ONE
<volume>4</volume>:<fpage>e7095</fpage>.<pub-id pub-id-type="pmid">19763183</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0008">
<mixed-citation id="phy212769-cit-0008" publication-type="journal">
<string-name>
<surname>Chen</surname>, <given-names>K. B.</given-names>
</string-name>, <string-name>
<given-names>A. M.</given-names>
<surname>Lin</surname>
</string-name>, and <string-name>
<given-names>T. H.</given-names>
<surname>Chiu</surname>
</string-name>. <year>2003</year>
<article-title>Systemic vitamin D3 attenuated oxidative injuries in the locus coeruleus of rat brain</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>993</volume>:<fpage>313</fpage>–<lpage>324</lpage>; discussion 345‐249.<pub-id pub-id-type="pmid">12853323</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0009">
<mixed-citation id="phy212769-cit-0009" publication-type="journal">
<string-name>
<surname>Chopp</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>Z. G.</given-names>
<surname>Zhang</surname>
</string-name>, and <string-name>
<given-names>Q.</given-names>
<surname>Jiang</surname>
</string-name>. <year>2007</year>
<article-title>Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke</article-title>. <source/>Stroke
<volume>38</volume>(<issue>2 Suppl</issue>):<fpage>827</fpage>–<lpage>831</lpage>.<pub-id pub-id-type="pmid">17261747</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0010">
<mixed-citation id="phy212769-cit-0010" publication-type="journal">
<string-name>
<surname>Chowdhury</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Stevens</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Ward</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Chowdhury</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sajjad</surname>
</string-name>, and <string-name>
<given-names>O. H.</given-names>
<surname>Franco</surname>
</string-name>. <year>2012</year>
<article-title>Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta‐analysis</article-title>. <source/>Eur. J. Epidemiol.
<volume>27</volume>:<fpage>581</fpage>–<lpage>591</lpage>.<pub-id pub-id-type="pmid">22961293</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0011">
<mixed-citation id="phy212769-cit-0011" publication-type="journal">
<string-name>
<surname>Cranney</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Horsley</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>O'Donnell</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Weiler</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Puil</surname>
</string-name>, <string-name>
<given-names>D.</given-names> <surname>Ooi</surname>
</string-name>, et al. <year>2007</year>
<article-title>Effectiveness and safety of vitamin D in relation to bone health</article-title>. <source/>Evid. Rep. Technol. Assess. (Full Rep)
<volume>158</volume>:<fpage>1</fpage>–<lpage>235</lpage>.<pub-id pub-id-type="pmid">18088161</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0012">
<mixed-citation id="phy212769-cit-0012" publication-type="journal">
<string-name>
<surname>Cui</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<given-names>J. J.</given-names>
<surname>McGrath</surname>
</string-name>, <string-name>
<given-names>T. H.</given-names>
<surname>Burne</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Mackay‐Sim</surname>
</string-name>, and <string-name>
<given-names>D. W.</given-names>
<surname>Eyes</surname>
</string-name>. <year>2007</year>
<article-title>Maternal vitamin D depletion alters neurogenesis in the developing rat brain</article-title>. <source/>Int. J. Dev. Neurosci.
<volume>25</volume>:<fpage>227</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">17467223</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0013">
<mixed-citation id="phy212769-cit-0013" publication-type="journal">
<string-name>
<surname>Dang</surname>, <given-names>T. N.</given-names>
</string-name>, <string-name>
<given-names>S. R.</given-names>
<surname>Robinson</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Dringen</surname>
</string-name>, and <string-name>
<given-names>G. M.</given-names>
<surname>Bishop</surname>
</string-name>. <year>2011</year>
<article-title>Uptake, metabolism and toxicity of hemin in cultured neurons</article-title>. <source/>Neurochem. Int.
<volume>58</volume>:<fpage>804</fpage>–<lpage>811</lpage>.<pub-id pub-id-type="pmid">21397650</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0014">
<mixed-citation id="phy212769-cit-0014" publication-type="journal">
<string-name>
<surname>Dev</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Kumari</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Singh</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Kumar Bal</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Seth</surname>
</string-name>, and <string-name>
<given-names>C. K.</given-names>
<surname>Mukhopadhyay</surname>
</string-name>. <year>2015</year>
<article-title>Role of extracellular Hydrogen peroxide in regulation of iron homeostasis genes in neuronal cells: implication in iron accumulation</article-title>. <source/>Free Radic. Biol. Med.
<volume>86</volume>:<fpage>78</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">26006106</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0015">
<mixed-citation id="phy212769-cit-0015" publication-type="journal">
<string-name>
<surname>Eyles</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Brown</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Mackay‐Sim</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>McGrath</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Feron</surname>
</string-name>. <year>2003</year>
<article-title>Vitamin D3 and brain development</article-title>. <source/>Neuroscience
<volume>118</volume>:<fpage>641</fpage>–<lpage>653</lpage>.<pub-id pub-id-type="pmid">12710973</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0016">
<mixed-citation id="phy212769-cit-0016" publication-type="journal">
<string-name>
<surname>Eyles</surname>, <given-names>D. W.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Smith</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kinobe</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Hewison</surname>
</string-name>, and <string-name>
<given-names>J. J.</given-names>
<surname>McGreath</surname>
</string-name>. <year>2005</year>
<article-title>Distribution of the vitamin D receptor and 1 alpha‐hydroxylase in human brain</article-title>. <source/>J. Chem. Neuroanat.
<volume>29</volume>:<fpage>21</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">15589699</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0017">
<mixed-citation id="phy212769-cit-0017" publication-type="journal">
<string-name>
<surname>Filograna</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Civiero</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Ferrari</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Codolo</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Greggio</surname>
</string-name>, <string-name>
<given-names>L.</given-names> <surname>Bubacco</surname>
</string-name>, et al. <year>2015</year>
<article-title>Analysis of the catecholaminergic phenotype in human SH‐SY5Y and BE(2)‐M17 neuroblastoma cell lines upon differentiation</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0136769</fpage>.<pub-id pub-id-type="pmid">26317353</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0018">
<mixed-citation id="phy212769-cit-0018" publication-type="journal">
<string-name>
<surname>Gao</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Campian</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Qian</surname>
</string-name>, <string-name>
<given-names>X. F.</given-names>
<surname>Sun</surname>
</string-name>, and <string-name>
<given-names>J. W.</given-names>
<surname>Eaton</surname>
</string-name>. <year>2009</year>
<article-title>Mitochondrial DNA damage in iron overload</article-title>. <source/>J. Biol. Chem.
<volume>284</volume>:<fpage>4767</fpage>–<lpage>4775</lpage>.<pub-id pub-id-type="pmid">19095657</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0019">
<mixed-citation id="phy212769-cit-0019" publication-type="journal">
<string-name>
<surname>Garcion</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Nataf</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Berod</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Darcy</surname>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Brachet</surname>
</string-name>. <year>1997</year>
<article-title>1,25‐DihydroxyVitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis</article-title>. <source/>Brain Res. Mol. Brain Res.
<volume>45</volume>:<fpage>255</fpage>–<lpage>267</lpage>.<pub-id pub-id-type="pmid">9149100</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0020">
<mixed-citation id="phy212769-cit-0020" publication-type="journal">
<string-name>
<surname>Garcion</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Wion‐Barbot</surname>
</string-name>, <string-name>
<given-names>C. N.</given-names>
<surname>Montero‐Menei</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Berger</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Wion</surname>
</string-name>. <year>2002</year>
<article-title>New clues about vitamin D functions in the nervous system</article-title>. <source/>Trends Endocrinol. Metab.
<volume>13</volume>:<fpage>100</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">11893522</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0021">
<mixed-citation id="phy212769-cit-0021" publication-type="journal">
<string-name>
<surname>Gotz</surname>, <given-names>M. E.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Double</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Gerlach</surname>
</string-name>, <string-name>
<given-names>M. B.</given-names>
<surname>Youdim</surname>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Riederer</surname>
</string-name>. <year>2004</year>
<article-title>The relevance of iron in the pathogenesis of Parkinson's disease</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>1012</volume>:<fpage>193</fpage>–<lpage>208</lpage>.<pub-id pub-id-type="pmid">15105267</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0022">
<mixed-citation id="phy212769-cit-0022" publication-type="journal">
<string-name>
<surname>Hentze</surname>, <given-names>M. W.</given-names>
</string-name>, and <string-name>
<given-names>L. C.</given-names>
<surname>Kuhn</surname>
</string-name>. <year>1996</year>
<article-title>Molecular control of vertebrate iron metabolism: mRNA based regulatory circuits operated by iron, nitric oxide, and oxidative stress</article-title>. <source/>Proc. Natl Acad. Sci. U. S. A.
<volume>93</volume>:<fpage>8175</fpage>–<lpage>8182</lpage>.<pub-id pub-id-type="pmid">8710843</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0023">
<mixed-citation id="phy212769-cit-0023" publication-type="journal">
<string-name>
<surname>Hentze</surname>, <given-names>M. W.</given-names>
</string-name>, <string-name>
<given-names>M. U.</given-names>
<surname>Muckenthaler</surname>
</string-name>, and <string-name>
<given-names>N. C.</given-names>
<surname>Andrews</surname>
</string-name>. <year>2004</year>
<article-title>Balancing acts: molecular control of mammalian iron metabolism</article-title>. <source/>Cell
<volume>117</volume>:<fpage>285</fpage>–<lpage>297</lpage>.<pub-id pub-id-type="pmid">15109490</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0024">
<mixed-citation id="phy212769-cit-0024" publication-type="journal">
<string-name>
<surname>Herold</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Kumar</surname>
</string-name>, <string-name>
<given-names>S. P.</given-names>
<surname>Wichert</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Kretzschmar</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Bahr</surname>
</string-name>, <string-name>
<given-names>M. J.</given-names>
<surname>Rosner</surname>
</string-name>, et al. <year>2015</year>
<article-title>Neurodegeneration in autoimmune optic neuritis is associated with altered app cleavage in neurons and up‐regulation of p53</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0138852</fpage>.<pub-id pub-id-type="pmid">26426258</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0025">
<mixed-citation id="phy212769-cit-0025" publication-type="journal">
<string-name>
<surname>Honmou</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Onodera</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Sasaki</surname>
</string-name>, <string-name>
<given-names>S. G.</given-names>
<surname>Waxman</surname>
</string-name>, and <string-name>
<given-names>J. D.</given-names>
<surname>Kocsis</surname>
</string-name>. <year>2012</year>
<article-title>Mesenchymal stem cells: therapeutic outlook for stroke</article-title>. <source/>Trends Mol. Med.
<volume>18</volume>:<fpage>292</fpage>–<lpage>297</lpage>.<pub-id pub-id-type="pmid">22459358</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0026">
<mixed-citation id="phy212769-cit-0026" publication-type="journal">
<string-name>
<surname>Ibi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Sawada</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Nakanishi</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Kume</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Katsuki</surname>
</string-name>, <string-name>
<given-names>S.</given-names> <surname>Kaneko</surname>
</string-name>, et al. <year>2001</year>
<article-title>Protective effects of 1 alpha,25‐(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture</article-title>. <source/>Neuropharmacology
<volume>40</volume>:<fpage>761</fpage>–<lpage>771</lpage>.<pub-id pub-id-type="pmid">11369030</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0027">
<mixed-citation id="phy212769-cit-0027" publication-type="journal">
<string-name>
<surname>Kalueff</surname>, <given-names>A. V.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Minasyan</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Keisala</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kuuslahti</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Miettinen</surname>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Tuohimaa</surname>
</string-name>. <year>2006</year>
<article-title>The vitamin D neuroendocrine system as a target for novel neurotropic drugs</article-title>. <source/>CNS Neurol. Disord. Drug Targets
<volume>5</volume>:<fpage>363</fpage>–<lpage>371</lpage>.<pub-id pub-id-type="pmid">16787236</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0028">
<mixed-citation id="phy212769-cit-0028" publication-type="journal">
<string-name>
<surname>Kienreich</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Grubler</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Tomaschitz</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Schmid</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Verheyen</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Rutters</surname>
</string-name>, et al. <year>2013</year>
<article-title>Vitamin D, arterial hypertension &amp; cerebrovascular disease</article-title>. <source/>Indian J. Med. Res.
<volume>137</volume>:<fpage>669</fpage>–<lpage>679</lpage>.<pub-id pub-id-type="pmid">23703334</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0030">
<mixed-citation id="phy212769-cit-0030" publication-type="journal">
<string-name>
<surname>Lattuada</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Uberti</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Colciaghi</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Morsanuto</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Maldi</surname>
</string-name>, <string-name>
<given-names>D. F.</given-names>
<surname>Squarzanti</surname>
</string-name>, et al. <year>2015</year>
<article-title>Fimbrial cells exposure to catalytic iron mimics carcinogenic changes</article-title>. <source/>Int. J. Gynecol. Cancer
<volume>25</volume>:<fpage>389</fpage>–<lpage>398</lpage>.<pub-id pub-id-type="pmid">25594146</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0031">
<mixed-citation id="phy212769-cit-0031" publication-type="journal">
<string-name>
<surname>Lee</surname>, <given-names>S. H.</given-names>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>J. Y.</given-names>
<surname>Chung</surname>
</string-name>, <string-name>
<given-names>Y. S.</given-names>
<surname>Jung</surname>
</string-name>, <string-name>
<given-names>S. Y.</given-names>
<surname>Choi</surname>
</string-name>, <string-name>
<given-names>S. H.</given-names>
<surname>Hwang</surname>
</string-name>, et al. <year>2009</year>
<article-title>p53, secreted by K‐Ras‐Snail pathway, is endocytosed by K‐ras‐mutated cells; implication of target‐specific drug delivery and early diagnostic marker</article-title>. <source/>Oncogene
<volume>28</volume>:<fpage>2005</fpage>–<lpage>2014</lpage>.<pub-id pub-id-type="pmid">19347028</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0032">
<mixed-citation id="phy212769-cit-0032" publication-type="journal">
<string-name>
<surname>Lipinski</surname>, <given-names>B.</given-names>
</string-name>
<year>2011</year>
<article-title>Hydroxyl radical and its scavengers in health and disease</article-title>. <source/>Oxid. Med. Cell Longev.
<volume>2011</volume>:<fpage>809696</fpage>.<pub-id pub-id-type="pmid">21904647</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0033">
<mixed-citation id="phy212769-cit-0033" publication-type="journal">
<string-name>
<surname>Meguro</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Asano</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Odagiri</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Iwatsuki</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Shoumura</surname>
</string-name>. <year>2007</year>
<article-title>Nonheme‐iron histochemistry for light and electron microscopy: a historical, theoretical and technical review</article-title>. <source/>Arch. Histol. Cytol.
<volume>70</volume>:<fpage>1</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">17558140</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0034">
<mixed-citation id="phy212769-cit-0034" publication-type="journal">
<string-name>
<surname>Mena</surname>, <given-names>N. P.</given-names>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>García‐Beltrán</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Lourido</surname>
</string-name>, <string-name>
<given-names>P. J.</given-names>
<surname>Urrutia</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Mena</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Castro‐Castillo</surname>
</string-name>, et al. <year>2015</year>
<article-title>The novel mitochondrial iron chelator 5‐((methylamino)methyl)‐8‐hydroxyquinoline protects against mitochondrial‐induced oxidative damage and neuronal death</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>463</volume>:<fpage>787</fpage>–<lpage>792</lpage>.<pub-id pub-id-type="pmid">26051278</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0035">
<mixed-citation id="phy212769-cit-0035" publication-type="journal">
<string-name>
<surname>Molinari</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Uberti</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Grossini</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Vacca</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Carda</surname>
</string-name>, <string-name>
<given-names>M.</given-names> <surname>Invernizzi</surname>
</string-name>, et al. <year>2011</year>
<article-title>1<italic>α</italic>,25‐dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells</article-title>. <source/>Cell. Physiol. Biochem.
<volume>27</volume>:<fpage>661</fpage>–<lpage>668</lpage>.<pub-id pub-id-type="pmid">21691084</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0036">
<mixed-citation id="phy212769-cit-0036" publication-type="journal">
<string-name>
<surname>Moos</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Rosengren Nielsen</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Skjørringe</surname>
</string-name>, and <string-name>
<given-names>E. H.</given-names> <surname>Morgan</surname>
</string-name>. <year>2007</year>
<article-title>Iron trafficking inside the brain</article-title>. <source/>J. Neurochem.
<volume>103</volume>:<fpage>1730</fpage>–<lpage>1740</lpage>.<pub-id pub-id-type="pmid">17953660</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0037">
<mixed-citation id="phy212769-cit-0037" publication-type="journal">
<string-name>
<surname>Mura</surname>, <given-names>C. V.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Delgado</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Aguirre</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Bacigalupo</surname>
</string-name>, and <string-name>
<given-names>M. T.</given-names>
<surname>Núñez</surname>
</string-name>. <year>2006</year>
<article-title>Quiescence induced by iron challenge protects neuroblastoma cells from oxidative stress</article-title>. <source/>J. Neurochem.
<volume>98</volume>:<fpage>11</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">16805792</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0038">
<mixed-citation id="phy212769-cit-0038" publication-type="journal">
<string-name>
<surname>Owen</surname>, <given-names>J. E.</given-names>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Bishop</surname>
</string-name>, and <string-name>
<given-names>S. R.</given-names>
<surname>Robinson</surname>
</string-name>. <year>2016</year>
<article-title>Uptake and toxicity of hemin and iron in cultured mouse astrocytes</article-title>. <source/>Neurochem. Res.
<volume>41</volume>:<fpage>298</fpage>–<lpage>306</lpage>.<pub-id pub-id-type="pmid">26694650</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0039">
<mixed-citation id="phy212769-cit-0039" publication-type="journal">
<string-name>
<surname>Park</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>D. G.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Park</surname>
</string-name>, <string-name>
<given-names>J. H.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>S. R.</given-names>
<surname>Lee</surname>
</string-name>, et al. <year>2015</year>
<article-title>Iron overload triggers mitochondrial fragmentation via calcineurin‐sensitive signals in HT‐22 hippocampal neuron cells</article-title>. <source/>Toxicology
<volume>337</volume>:<fpage>39</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">26318285</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0040">
<mixed-citation id="phy212769-cit-0040" publication-type="journal">
<string-name>
<surname>Pelizzoni</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Macco</surname>
</string-name>, <string-name>
<given-names>M. F.</given-names>
<surname>Morini</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Zacchetti</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Grohovaz</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Codazzi</surname>
</string-name>. <year>2011</year>
<article-title>Iron handling in hippocampal neurons: activity‐dependent iron entry and mitochondria‐mediated neurotoxicity</article-title>. <source/>Aging Cell
<volume>10</volume>:<fpage>172</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">21108725</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0041">
<mixed-citation id="phy212769-cit-0041" publication-type="journal">
<string-name>
<surname>Pilz</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Tomaschitz</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Drechsler</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Zittermann</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Dekker</surname>
</string-name>, and <string-name>
<given-names>W.</given-names>
<surname>Marz</surname>
</string-name>. <year>2011</year>
<article-title>Vitamin D supplementation: a promising approach for the prevention and treatment of strokes</article-title>. <source/>Curr. Drug Targets
<volume>12</volume>:<fpage>88</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">20795935</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0042">
<mixed-citation id="phy212769-cit-0042" publication-type="journal">
<string-name>
<surname>Pittarella</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>D. F.</given-names>
<surname>Squarzanti</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Molinari</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Invernizzi</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Uberti</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Renò</surname>
</string-name>. <year>2015</year>
<article-title>NO‐dependent proliferation and migration induced by Vitamin D in HUVEC</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>149</volume>:<fpage>35</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">25616003</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0043">
<mixed-citation id="phy212769-cit-0043" publication-type="journal">
<string-name>
<surname>Ponka</surname>, <given-names>P.</given-names>
</string-name>
<year>2004</year>
<article-title>Hereditary causes of disturbed iron homeostasis in the central nervous system</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>1012</volume>:<fpage>267</fpage>–<lpage>281</lpage>.<pub-id pub-id-type="pmid">15105272</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0044">
<mixed-citation id="phy212769-cit-0044" publication-type="journal">
<string-name>
<surname>Prüfer</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>T. D.</given-names>
<surname>Veenstra</surname>
</string-name>, <string-name>
<given-names>G. F.</given-names>
<surname>Jirikowski</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Kumar</surname>
</string-name>. <year>1999</year>
<article-title>Distribution of 1,25‐dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord</article-title>. <source/>J. Chem. Neuroanat.
<volume>16</volume>:<fpage>135</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">10223312</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0045">
<mixed-citation id="phy212769-cit-0045" publication-type="journal">
<string-name>
<surname>Rouault</surname>, <given-names>T. A.</given-names>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Cooperman</surname>
</string-name>. <year>2006</year>
<article-title>Brain iron metabolism</article-title>. <source/>Semin. Pediatr. Neurol.
<volume>13</volume>:<fpage>142</fpage>–<lpage>148</lpage>.<pub-id pub-id-type="pmid">17101452</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0046">
<mixed-citation id="phy212769-cit-0046" publication-type="journal">
<string-name>
<surname>Salvador</surname>, <given-names>G. A.</given-names>
</string-name>
<year>2010</year>
<article-title>Iron in neuronal function and dysfunction</article-title>. <source/>BioFactors
<volume>36</volume>:<fpage>103</fpage>–<lpage>110</lpage>.<pub-id pub-id-type="pmid">20232345</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0047">
<mixed-citation id="phy212769-cit-0047" publication-type="journal">
<string-name>
<surname>Salvador</surname>, <given-names>G. A.</given-names>
</string-name>, and <string-name>
<given-names>P. I.</given-names>
<surname>Oteiza</surname>
</string-name>. <year>2011</year>
<article-title>Iron overload triggers redox‐sensitive signals in human IMR‐32 neuroblastoma cells</article-title>. <source/>Neurotoxicology
<volume>32</volume>:<fpage>75</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">21130806</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0048">
<mixed-citation id="phy212769-cit-0048" publication-type="journal">
<string-name>
<surname>Singh</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Haldar</surname>
</string-name>, <string-name>
<given-names>A. K.</given-names>
<surname>Tripathi</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Horback</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Wuong</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Sharma</surname>
</string-name>, et al. <year>2014</year>
<article-title>Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities</article-title>. <source/>Antioxid. Redox Signal.
<volume>20</volume>:<fpage>1324</fpage>–<lpage>1363</lpage>.<pub-id pub-id-type="pmid">23815406</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0049">
<mixed-citation id="phy212769-cit-0049" publication-type="journal">
<string-name>
<surname>Sipe</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Lee</surname>
</string-name>, and <string-name>
<given-names>E.</given-names>
<surname>Beutler</surname>
</string-name>. <year>2002</year>
<article-title>Brain iron metabolism and neurodegenerative disorders</article-title>. <source/>Dev. Neurosci.
<volume>24</volume>:<fpage>188</fpage>–<lpage>196</lpage>.<pub-id pub-id-type="pmid">12401958</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0050">
<mixed-citation id="phy212769-cit-0050" publication-type="journal">
<string-name>
<surname>Sleiman</surname>, <given-names>S. F.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Berlin</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Basso</surname>
</string-name>, <string-name>
<given-names>S. S.</given-names>
<surname>Karuppagounder</surname>
</string-name>, <string-name>
<given-names>J.</given-names> <surname>Rohr</surname>
</string-name>, and <string-name>
<given-names>R. R.</given-names>
<surname>Ratan</surname>
</string-name>. <year>2011</year>
<article-title>Histone deacetylase inhibitors and mithramycin a impact a similar neuroprotective pathway at a crossroad between cancer and neurodegeneration</article-title>. <source/>Pharmaceuticals (Basel)
<volume>4</volume>:<fpage>1183</fpage>–<lpage>1195</lpage>.<pub-id pub-id-type="pmid">22582024</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0051">
<mixed-citation id="phy212769-cit-0051" publication-type="journal">
<string-name>
<surname>Smith</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<given-names>P. L.</given-names>
<surname>Harris</surname>
</string-name>, <string-name>
<given-names>L. M.</given-names>
<surname>Sayre</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Perry</surname>.</string-name>
<year>1997</year>
<article-title>Iron accumulation in Alzheimer disease is a source of redox‐generated free radicals</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>94</volume>:<fpage>9866</fpage>–<lpage>9868</lpage>.<pub-id pub-id-type="pmid">9275217</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0052">
<mixed-citation id="phy212769-cit-0052" publication-type="journal">
<string-name>
<surname>Stewart</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Wong</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Cachat</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Elegante</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Gilder</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Mohonot</surname>
</string-name>, et al. <year>2010</year>
<article-title>Neurosteroid vitamin D system as a nontraditional drug target in neuropsychopharmacology</article-title>. <source/>Behav. Pharmacol.
<volume>21</volume>:<fpage>420</fpage>–<lpage>426</lpage>.<pub-id pub-id-type="pmid">20571365</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0053">
<mixed-citation id="phy212769-cit-0053" publication-type="journal">
<string-name>
<surname>Sun</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Pan</surname>
</string-name>, <string-name>
<given-names>F. B.</given-names>
<surname>Hu</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Manson</surname>
</string-name>, and <string-name>
<given-names>K. M.</given-names>
<surname>Rexrode</surname>
</string-name>. <year>2012</year>
<article-title>25‐hydroxyvitamin D levels and the risk of stroke: a prospective study and meta‐analysis</article-title>. <source/>Stroke
<volume>43</volume>:<fpage>1470</fpage>–<lpage>1477</lpage>.<pub-id pub-id-type="pmid">22442173</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0054">
<mixed-citation id="phy212769-cit-0054" publication-type="journal">
<string-name>
<surname>Takanashi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Mochizuki</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Yokomizo</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Hattori</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Mori</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Yamamura</surname>
</string-name>, et al. <year>2001</year>
<article-title>Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP)</article-title>. <source/>Parkinsonism Relat. Disord.
<volume>7</volume>:<fpage>311</fpage>–<lpage>314</lpage>.<pub-id pub-id-type="pmid">11344015</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0055">
<mixed-citation id="phy212769-cit-0055" publication-type="journal">
<string-name>
<surname>Tetich</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kutner</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Leskiewicz</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Budziszewska</surname>
</string-name>, and <string-name>
<given-names>W.</given-names> <surname>Lasoń</surname>
</string-name>. <year>2004</year>
<article-title>Neuroprotective effects of (24R)‐1,24‐dihydroxycholecalciferol in human neuroblastoma SH‐SY5Y cell line</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>89‐90</volume>:<fpage>365</fpage>–<lpage>370</lpage>.</mixed-citation>
</ref>
<ref id="phy212769-bib-0056">
<mixed-citation id="phy212769-cit-0056" publication-type="journal">
<string-name>
<surname>Tetich</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Dziedzicka‐Wasylewska</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kusmider</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kutner</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Leskiewicz</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Jaworska‐Feil</surname>
</string-name>, et al. <year>2005</year>
<article-title>Effects of PRI‐2191—a low‐calcemic analog of 1,25‐dihydroxyvitamin D3 on the seizure‐induced changes in brain gene expression and immune system activity in the rat</article-title>. <source/>Brain Res.
<volume>1039</volume>:<fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">15781040</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0057">
<mixed-citation id="phy212769-cit-0057" publication-type="journal">
<string-name>
<surname>Thompson</surname>, <given-names>P. D.</given-names>
</string-name>, <string-name>
<given-names>P. W.</given-names>
<surname>Jurutka</surname>
</string-name>, <string-name>
<given-names>C. A.</given-names>
<surname>Haussler</surname>
</string-name>, <string-name>
<given-names>G. K.</given-names>
<surname>Whitfield</surname>
</string-name>, and <string-name>
<given-names>M. R.</given-names>
<surname>Haussler</surname>
</string-name>. <year>1998</year>
<article-title>Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25‐dihydroxyvitamin D3 and inhibited by 9‐cisretinoic acid. Evidence for allosteric receptor interactions</article-title>. <source/>J. Biol. Chem.
<volume>273</volume>:<fpage>8483</fpage>–<lpage>8491</lpage>.<pub-id pub-id-type="pmid">9525962</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0058">
<mixed-citation id="phy212769-cit-0058" publication-type="journal">
<string-name>
<surname>Uberti</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Lattuada</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Morsanuto</surname>
</string-name>, <string-name>
<given-names>U.</given-names>
<surname>Nava</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Bolis</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Vacca</surname>
</string-name>, et al. <year>2014</year>
<article-title>Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>99</volume>:<fpage>1367</fpage>–<lpage>1374</lpage>.<pub-id pub-id-type="pmid">24285680</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0059">
<mixed-citation id="phy212769-cit-0059" publication-type="journal">
<string-name>
<surname>Urrutia</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Aguirre</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Esparza</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Tapia</surname>
</string-name>, <string-name>
<given-names>N. P.</given-names>
<surname>Mena</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Arredondo</surname>
</string-name>, et al. <year>2013</year>
<article-title>Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells</article-title>. <source/>J. Neurochem.
<volume>126</volume>:<fpage>541</fpage>–<lpage>549</lpage>.<pub-id pub-id-type="pmid">23506423</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0060">
<mixed-citation id="phy212769-cit-0060" publication-type="journal">
<string-name>
<surname>Urrutia</surname>, <given-names>P. J.</given-names>
</string-name>, <string-name>
<given-names>N. P.</given-names>
<surname>Mena</surname>
</string-name>, and <string-name>
<given-names>M. T.</given-names>
<surname>Nunez</surname>
</string-name>. <year>2014</year>
<article-title>The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders</article-title>. <source/>Front. Pharmacol.
<volume>5</volume>:<fpage>38</fpage>.<pub-id pub-id-type="pmid">24653700</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0061">
<mixed-citation id="phy212769-cit-0061" publication-type="journal">
<string-name>
<surname>Wharton</surname>, <given-names>S. B.</given-names>
</string-name>, <string-name>
<given-names>G. H.</given-names>
<surname>Williams</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Stoeber</surname>
</string-name>, <string-name>
<given-names>C. H.</given-names>
<surname>Gelsthorpe</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Baxter</surname>
</string-name>, <string-name>
<given-names>A. L.</given-names>
<surname>Johnson</surname>
</string-name>, et al. <year>2005</year>
<article-title>Expression of Ki67, PCNA and the chromosome replication licensing protein Mcm2 in glial cells of the ageing human hippocampus increases with the burden of Alzheimer‐type pathology</article-title>. <source/>Neurosci. Lett.
<volume>383</volume>:<fpage>33</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">15936508</pub-id></mixed-citation>
</ref>
<ref id="phy212769-bib-0062">
<mixed-citation id="phy212769-cit-0062" publication-type="journal">
<string-name>
<surname>Zecca</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Gallorini</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Schünemann</surname>
</string-name>, <string-name>
<given-names>A. X.</given-names>
<surname>Trautwein</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Gerlach</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Riederer</surname>
</string-name>, et al. <year>2001</year>
<article-title>Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes</article-title>. <source/>J. Neurochem.
<volume>76</volume>:<fpage>1766</fpage>–<lpage>1773</lpage>.<pub-id pub-id-type="pmid">11259494</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>